blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4121522

EP4121522 - METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  23.12.2022
Database last updated on 31.08.2024
FormerThe international publication has been made
Status updated on  07.06.2022
Most recent event   Tooltip22.05.2024Supplementary search reportpublished on 19.06.2024  [2024/25]
Applicant(s)For all designated states
Intellia Therapeutics, Inc.
40 Erie Street
Cambridge, MA 02139 / US
[2023/04]
Inventor(s)01 / HALPERIN, Schaked Omer
1250 Powell Street, Apartment 4
Emeryville, California 94608 / US
 [2023/04]
Representative(s)Schlich, George William, et al
Schlich
9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
[N/P]
Former [2023/04]Schlich, George, et al
Schlich
9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
Application number, filing date21771405.418.03.2021
[2023/04]
WO2021US23041
Priority number, dateUS202062992032P19.03.2020         Original published format: US 202062992032 P
US202063055829P23.07.2020         Original published format: US 202063055829 P
US202163153161P24.02.2021         Original published format: US 202163153161 P
[2023/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021188840
Date:23.09.2021
Language:EN
[2021/38]
Type: A1 Application with search report 
No.:EP4121522
Date:25.01.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 23.09.2021 takes the place of the publication of the European patent application.
[2023/04]
Search report(s)International search report - published on:US23.09.2021
(Supplementary) European search report - dispatched on:EP21.05.2024
ClassificationIPC:C12N9/12, C12N9/22, C12N15/11, C12N15/52, C12N15/90
[2024/14]
CPC:
C12N9/22 (EP,KR,US); C12N9/1276 (EP,KR,US); C12N15/11 (US);
C12N15/111 (EP); C12N15/113 (KR,US); C12N15/52 (EP,US);
C12N15/907 (EP,KR,US); C12N2310/122 (KR,US); C12N2310/123 (EP,KR);
C12N2310/128 (EP,KR); C12N2310/20 (EP,KR,US); C12N2310/3519 (EP,KR,US);
C12N2310/531 (US); C12N2320/53 (EP,KR); C12N2800/80 (KR,US) (-)
Former IPC [2023/04]C12N9/12, C12N9/22
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/04]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR GERICHTETEN GENOMEDITIERUNG[2023/04]
English:METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING[2023/04]
French:MÉTHODES ET COMPOSITIONS POUR L'ÉDITION GÉNOMIQUE DIRIGÉE[2023/04]
Entry into regional phase03.10.2022National basic fee paid 
03.10.2022Search fee paid 
03.10.2022Designation fee(s) paid 
03.10.2022Examination fee paid 
Examination procedure03.10.2022Examination requested  [2023/04]
20.04.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
03.10.2022Renewal fee patent year 03
27.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2002192788  (IHLENFELDT HANS-GEORG [DE], et al);
 [Y]US2014010839  (BENKIRANE MONSEF [FR], et al);
 [X]WO2018049168  (UNIV LELAND STANFORD JUNIOR [US]);
 [Y]US2018230494  (JOUNG J KEITH [US], et al);
 [X]US2018237770  (MAY ANDREW PAUL [US], et al);
 [Y]US2018298414  (JANULAITIS ARVYDAS [LT], et al);
 [Y]US2018313843  (KEPPLER OLIVER TILL [DE], et al);
 [A]US2019062409  (LUBAN JEREMY [US]);
 [Y]WO2019070843  (UNIV TEXAS [US]);
 [XY]US2019350978  (BEAUCHESNE PASCAL [US], et al);
 [X]WO2020012335  (ALIA THERAPEUTICS S R L [IT]);
 [Y]US2020038424  (HIRANO MICHIO [US], et al);
 [XY]WO2020047124  (FLAGSHIP PIONEERING INC [US]);
 [X]WO2020051561  (BEAM THERAPEUTICS INC [US]);
 [PX]WO2020191153  (BROAD INST INC [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.